CPS Logo

All Publications

2024

figure from publication

ASHP and ASHP Foundation Pharmacy Forecast 2024: Strategic planning guidance for pharmacy departments in hospitals and health systems

DiPiro JT, Hoffman JM, Schweitzer P, Chisholm-Burns MA, Nesbit TW, Fabian TJ, Cunningham FE, Barrett A, Fine MJ, Tichy E, Hernandez I, Scott CM, Norman C, Nelson SD, Kumah-Crystal Y.

Am J Health Syst Pharm. 2024 Jan 5;81(2):5-36. doi: 10.1093/ajhp/zxad231. PMID: 38048298.

Read More... from ASHP and ASHP Foundation Pharmacy Forecast 2024: Strategic planning guidance for pharmacy departments in hospitals and health systems

2023

Photo of chromatograms from the article

Development and validation of an ultra-high performance liquid chromatography-tandem mass spectrometry method for quantifying lenacapavir plasma concentrations: Application to therapeutic monitoring

West RE 3rd, Oberly PJ, Riddler SA, Nolin TD, Devanathan AS.

J Chromatogr B Analyt Technol Biomed Life Sci. 2023 Nov 15;1230:123905. Epub 2023 Oct 15. doi: 10.1016/j.jchromb.2023.123905. PubMed PMID: 37866010

Read More... from Development and validation of an ultra-high performance liquid chromatography-tandem mass spectrometry method for quantifying lenacapavir plasma concentrations: Application to therapeutic monitoring

Figure from Shaik's publication

Simultaneous quantitation of ketamine, norketamine and dehydronorketamine in human milk using a novel ultra high-performance liquid chromatography-mass spectrometry (UPLC-MS/MS) assay

Shahane A, Zhao W, Pakalapati N, Alshogran OY, Caritis SN, Lim G, Shaik IH, Venkataramanan R.

J Pharm Biomed Anal. 2023 Sep 20. DOI: 10.1016/j.jpba.2023.115502. PMID: 37311376.

Read More... from Simultaneous quantitation of ketamine, norketamine and dehydronorketamine in human milk using a novel ultra high-performance liquid chromatography-mass spectrometry (UPLC-MS/MS) assay

Figure from article

Exacerbated lung inflammation following secondary RSV exposure is CD4+ T cell-dependent and is not mitigated in infant BALB/c mice born to PreF-vaccinated dams

Kosanovich JL, Eichinger KM, Lipp MA, Gidwani SV, Brahmbhatt D, Yondola MA, Perkins TN, Empey KM.

Front Immunol. 2023 Aug 14:14:1206026. DOI: 10.3389/fimmu.2023.1206026. PMID: 37646035.

Read More... from Exacerbated lung inflammation following secondary RSV exposure is CD4+ T cell-dependent and is not mitigated in infant BALB/c mice born to PreF-vaccinated dams

Figure from article

Tenofovir vaginal film as a potential MPT product against HIV-1 and HSV-2 acquisition: formulation development and preclinical assessment in non-human primates

Patel SK, Agashe H, Patton DL, Sweeney Y, Beamer MA, Hendrix CW, Hillier SL, Rohan LC

Front Reprod Health. 2023 Aug 10:5:1217835. DOI: 10.3389/frph.2023.1217835 PMID: 37638127

Read More... from Tenofovir vaginal film as a potential MPT product against HIV-1 and HSV-2 acquisition: formulation development and preclinical assessment in non-human primates